Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-13.57%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$10.9B
Cap. Flow %
12.9%
Top 10 Hldgs %
10.97%
Holding
4,738
New
700
Increased
1,959
Reduced
1,484
Closed
563

Sector Composition

1 Healthcare 19.41%
2 Technology 16.81%
3 Consumer Staples 11.14%
4 Consumer Discretionary 10.11%
5 Financials 8.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WNW icon
4001
Meiwu Technology Co
WNW
$6.23M
$48K ﹤0.01%
118
+88
+293% +$35.8K
ELOX
4002
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$48K ﹤0.01%
+4,485
New +$48K
BCLI
4003
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$47K ﹤0.01%
+1,140
New +$47K
TOVX icon
4004
Theriva Biologics
TOVX
$3.72M
$47K ﹤0.01%
876
+446
+104% +$23.9K
SNAX
4005
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$47K ﹤0.01%
3,533
+1,820
+106% +$24.2K
CRXT
4006
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$47K ﹤0.01%
122,277
+87,577
+252% +$33.7K
AKTX
4007
Akari Therapeutics
AKTX
$27.7M
$46K ﹤0.01%
2,298
-15
-0.6% -$300
BINI
4008
Bollinger Innovations, Inc. Common Stock
BINI
$4.56M
0
OBLG icon
4009
Oblong
OBLG
$6.39M
$46K ﹤0.01%
245
-102
-29% -$19.2K
QNTM
4010
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM
$49.6M
$46K ﹤0.01%
905
+403
+80% +$20.5K
EVK
4011
DELISTED
Ever-Glory International Group, Inc.
EVK
$46K ﹤0.01%
34,900
-1,100
-3% -$1.45K
ADAG
4012
Adagene
ADAG
$113M
$45K ﹤0.01%
+21,794
New +$45K
RMTI icon
4013
Rockwell Medical
RMTI
$54.7M
$45K ﹤0.01%
35,015
+9,448
+37% +$12.1K
UCL
4014
uCloudlink Group
UCL
$108M
$45K ﹤0.01%
40,005
+7,205
+22% +$8.11K
MOHO
4015
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$45K ﹤0.01%
276,707
-16,700
-6% -$2.72K
LIXT icon
4016
Lixte Biotechnology
LIXT
$19.7M
$43K ﹤0.01%
+5,719
New +$43K
ALAR
4017
Alarum Technologies
ALAR
$105M
$42K ﹤0.01%
8,602
+4,302
+100% +$21K
LGMK
4018
DELISTED
LogicMark
LGMK
$42K ﹤0.01%
+78
New +$42K
ORC
4019
Orchid Island Capital
ORC
$962M
$42K ﹤0.01%
+2,920
New +$42K
EFTR
4020
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$42K ﹤0.01%
+1,172
New +$42K
AVGR
4021
DELISTED
Avinger, Inc. Common Stock
AVGR
$42K ﹤0.01%
+1,931
New +$42K
AYLA
4022
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$42K ﹤0.01%
+38,101
New +$42K
DS
4023
DELISTED
Drive Shack Inc.
DS
$42K ﹤0.01%
30,328
-520,672
-94% -$721K
CRTD
4024
DELISTED
Creatd Inc. Common Stock
CRTD
$42K ﹤0.01%
+57,494
New +$42K
ATXS icon
4025
Astria Therapeutics
ATXS
$419M
$41K ﹤0.01%
+13,700
New +$41K